|
Market Closed -
OTC Markets
03:05:26 19/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.4500 USD | -8.16% |
|
-2.17% | - |
| 04-06 | Zivo Bioscience Inc Signs Manufacturing Agreement with Cyanotech Corporation for Zivolife Algal Biomass | CI |
| 11-12 | Cyanotech Corporation, Q2 2026 Earnings Call, Nov 11, 2025 |
| Market Cap | 2.17M 1.88M 1.77M 1.61M 3.02M 208M 3.07M 20.73M 8.12M 104M 8.17M 7.99M 347M | P/E 2024 |
-0.36x | P/E 2025 | -0.77x |
|---|---|---|---|---|---|
| Enterprise Value | 13.48M 11.64M 10.96M 9.96M 18.73M 1.29B 19M 129M 50.36M 646M 50.62M 49.52M 2.15B | EV / Sales 2024 |
0.53x | EV / Sales 2025 | 0.57x |
| Free-Float |
67.23% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Cyanotech Corporation
| 1 day | -8.16% | ||
| 1 week | -2.17% | ||
| Current month | -15.06% | ||
| 1 month | -15.08% | ||
| 3 months | -13.46% | ||
| 6 months | +27.70% |
| 1 week | 0.45 |  | 0.5 |
| 1 month | 0.39 | | 0.53 |
| Current year | 0.23 | | 0.55 |
| 1 year | 0.23 | | 0.57 |
| 3 years | 0.12 | | 1.02 |
| 5 years | 0.12 | | 3.95 |
| 10 years | 0.12 | | 6.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Custer
CEO | Chief Executive Officer | 43 | 16/06/2022 |
Gerald Cysewski
CEO | Chief Executive Officer | 77 | 31/03/2016 |
| Director of Finance/CFO | 46 | 21/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Vied
BRD | Director/Board Member | 65 | 27/01/2015 |
David Mulder
BRD | Director/Board Member | 65 | 17/05/2016 |
Matthew Custer
BRD | Director/Board Member | 43 | 16/06/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/9/25 | Free | Chief Financial Officer | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% | ||
| 28/8/25 | Free | Director | 50,000 | 0.6987% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -8.16% | -2.17% | +31.58% | -47.42% | 3.26M | |
| +3.60% | +0.88% | +75.59% | +124.32% | 1,093B | |
| +3.33% | +4.35% | +53.82% | +57.17% | 653B | |
| +3.43% | +3.53% | +25.34% | +72.45% | 458B | |
| +1.35% | -2.17% | +40.98% | +41.50% | 355B | |
| +1.75% | -0.24% | +25.28% | +40.46% | 294B | |
| +2.13% | -0.32% | +0.58% | +10.77% | 248B | |
| +1.41% | +2.65% | +45.34% | +62.43% | 230B | |
| +1.35% | -3.53% | -14.72% | -52.63% | 203B | |
| +3.25% | +5.65% | +21.57% | +89.04% | 178B | |
| Average | +1.34% | +0.09% | +30.54% | +39.81% | 371.05B | |
| Weighted average by Cap. | +2.80% | +0.25% | +43.85% | +68.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.07M 19.93M 18.75M 17.04M 32.05M 2.21B 32.52M 220M 86.19M 1.11B 86.62M 84.74M 3.68B | 24.22M 20.91M 19.68M 17.88M 33.64M 2.32B 34.13M 231M 90.46M 1.16B 90.92M 88.94M 3.87B |
| Net income | -5.27M -4.55M -4.28M -3.89M -7.32M -505M -7.42M -50.21M -19.68M -252M -19.77M -19.35M -841M | -3.2M -2.77M -2.6M -2.37M -4.45M -307M -4.51M -30.53M -11.97M -153M -12.03M -11.76M -511M |
| Net Debt | 10.2M 8.81M 8.29M 7.53M 14.17M 977M 14.37M 97.2M 38.09M 489M 38.28M 37.45M 1.63B | 11.31M 9.77M 9.19M 8.35M 15.71M 1.08B 15.94M 108M 42.24M 542M 42.45M 41.53M 1.8B |
Employees
83
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/08/26 | US$0.4500 | -8.16% | 9,288 |
| 14/08/26 | US$0.4900 | +6.52% | 510 |
| 13/08/26 | US$0.4600 | 0.00% | 1,358 |
| 11/08/26 | US$0.4600 | -13.19% | 3,674 |
- Stock Market
- Stocks
- CYAN Stock
Select your edition
All financial news and data tailored to specific country editions
